(Q33406653)

English

Phase II study of pemetrexed as first-line treatment in elderly (≥75) non-squamous non-small-cell lung cancer: Kyoto Thoracic Oncology Research Group Trial 0901.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Phase II study of pemetrexed as first-line treatment in elderly (≥75) non-squamous non-small-cell lung cancer: Kyoto Thoracic Oncology Research Group Trial 0901. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

phase II clinical trial

0 references

author name string

Young Hak Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Masataka Hirabayashi

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Shinji Kosaka

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Junichi Nikaidoh

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Yasumichi Yamamoto

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Masatoshi Shimada

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Toshiya Toyazaki

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Hiroki Nagai

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Yuichi Sakamori

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Michiaki Mishima

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

27 March 2013

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

71

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1445-1451

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

https://scigraph.springernature.com/pub.10.1007/s00280-013-2142-9

0 references

Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2142-9

21 January 2018

Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2142-9

21 January 2018

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2142-9

21 January 2018

Treatment of advanced non-small-cell lung cancer: Italian Association of Thoracic Oncology (AIOT) clinical practice guidelines

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2142-9

21 January 2018

Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2142-9

21 January 2018

The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2142-9

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2142-9

21 January 2018

2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2142-9

21 January 2018

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2142-9

21 January 2018

Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2142-9

21 January 2018

EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non-small-cell lung cancer in an elderly population.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2142-9

21 January 2018

Comparison of the efficacy and safety of single-agent and doublet chemotherapy in advanced non-small cell lung cancer in the elderly: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2142-9

21 January 2018

Trends in chemotherapy for elderly patients with advanced non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2142-9

21 January 2018

Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, r

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2142-9

21 January 2018

Identifiers

10.1007/S00280-013-2142-9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33406653&oldid=1985592617"